235 related articles for article (PubMed ID: 22753445)
21. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.
Truong D; Brodsky M; Lew M; Brashear A; Jankovic J; Molho E; Orlova O; Timerbaeva S;
Parkinsonism Relat Disord; 2010 Jun; 16(5):316-23. PubMed ID: 20359934
[TBL] [Abstract][Full Text] [Related]
22. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
Carroll A; Barnes M; Comiskey C
Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
[TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
24. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study.
Fagien S; Cox SE; Finn JC; Werschler WP; Kowalski JW
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S2-9. PubMed ID: 17241410
[TBL] [Abstract][Full Text] [Related]
25. The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.
Feys P; D'hooghe MB; Nagels G; Helsen WF
Mult Scler; 2009 Mar; 15(3):371-8. PubMed ID: 19168602
[TBL] [Abstract][Full Text] [Related]
26. Botulinum Toxin Type A Injections as Monotherapy for Upper Limb Essential Tremor Using Kinematics.
Samotus O; Kumar N; Rizek P; Jog M
Can J Neurol Sci; 2018 Jan; 45(1):11-22. PubMed ID: 29157315
[TBL] [Abstract][Full Text] [Related]
27. The effect of cannabis on tremor in patients with multiple sclerosis.
Fox P; Bain PG; Glickman S; Carroll C; Zajicek J
Neurology; 2004 Apr; 62(7):1105-9. PubMed ID: 15079008
[TBL] [Abstract][Full Text] [Related]
28. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.
Brin MF; Lyons KE; Doucette J; Adler CH; Caviness JN; Comella CL; Dubinsky RM; Friedman JH; Manyam BV; Matsumoto JY; Pullman SL; Rajput AH; Sethi KD; Tanner C; Koller WC
Neurology; 2001 Jun; 56(11):1523-8. PubMed ID: 11402109
[TBL] [Abstract][Full Text] [Related]
29. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
[TBL] [Abstract][Full Text] [Related]
30. The occurrence of dystonia in upper-limb multiple sclerosis tremor.
Van der Walt A; Buzzard K; Sung S; Spelman T; Kolbe SC; Marriott M; Butzkueven H; Evans A
Mult Scler; 2015 Dec; 21(14):1847-55. PubMed ID: 26014602
[TBL] [Abstract][Full Text] [Related]
31. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
Truong D; Duane DD; Jankovic J; Singer C; Seeberger LC; Comella CL; Lew MF; Rodnitzky RL; Danisi FO; Sutton JP; Charles PD; Hauser RA; Sheean GL
Mov Disord; 2005 Jul; 20(7):783-91. PubMed ID: 15736159
[TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin A injections for the treatment of hand tremors.
Trosch RM; Pullman SL
Mov Disord; 1994 Nov; 9(6):601-9. PubMed ID: 7845399
[TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study.
Evers S; Vollmer-Haase J; Schwaag S; Rahmann A; Husstedt IW; Frese A
Cephalalgia; 2004 Oct; 24(10):838-43. PubMed ID: 15377314
[TBL] [Abstract][Full Text] [Related]
35. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
Saper JR; Mathew NT; Loder EW; DeGryse R; VanDenburgh AM;
Pain Med; 2007 Sep; 8(6):478-85. PubMed ID: 17716321
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin.
Rose AE; Goldberg DJ
Dermatol Surg; 2013 Mar; 39(3 Pt 1):443-8. PubMed ID: 23293895
[TBL] [Abstract][Full Text] [Related]
37. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
Sahai A; Dowson C; Khan MS; Dasgupta P
BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
[TBL] [Abstract][Full Text] [Related]
39. OnabotulinumtoxinA treatment for MS-tremor modifies fMRI tremor response in central sensory-motor integration areas.
Boonstra FMC; Evans A; Noffs G; Perera T; Jokubaitis V; Stankovich J; Vogel AP; Moffat BA; Butzkueven H; Kolbe SC; van der Walt A
Mult Scler Relat Disord; 2020 May; 40():101984. PubMed ID: 32062446
[TBL] [Abstract][Full Text] [Related]
40. Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series.
Papapetropoulos S; Singer C
Clin Neuropharmacol; 2006; 29(6):364-7. PubMed ID: 17095901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
